Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy

Doripenem is a broad-spectrum parenteral carbapenem with enhanced activity against Pseudomonas aeruginosa and Enterobacteriaceae. Current dosing regimens recommend the administration of 0.25 to 0.5 g once daily in patients undergoing intermittent renal replacement therapy. As patients are usually di...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Vossen, M. G., Ehmann, L., Pferschy, S., Maier-Salamon, A., Haidinger, M., Weiser, C., Wenisch, J. M., Saria, K., Kajahn, C., Jilch, S., Lemmerer, R., Bécède, M., Zeitlinger, M., Kloft, C., Jäger, W., Thalhammer, F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5923130/
https://ncbi.nlm.nih.gov/pubmed/29530855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02430-17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados